Do product innovation and news about the R&D process produce large price changes and overreaction? The case of pharmaceutical stock prices
- DOI
- 10.1080/00036846.2011.562172
- Published
- 2011-04-15
- Container
- Applied Economics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/00036846.2011.562172,
title = {Do product innovation and news about the R\&D process produce large price changes and overreaction? The case of pharmaceutical stock prices},
author = {Jorge Pérez-Rodríguez and Beatriz G Valcarcel},
year = {2011},
journal = {Applied Economics},
doi = {10.1080/00036846.2011.562172},
url = {https://doi.org/10.1080/00036846.2011.562172}
}RIS
TY - JOUR TI - Do product innovation and news about the R&D process produce large price changes and overreaction? The case of pharmaceutical stock prices AU - Jorge Pérez-Rodríguez AU - Beatriz G Valcarcel PY - 2011 JO - Applied Economics DO - 10.1080/00036846.2011.562172 UR - https://doi.org/10.1080/00036846.2011.562172 ER -
APA
Pérez-Rodríguez, J., & Valcarcel, B. G. (2011). Do product innovation and news about the R&D process produce large price changes and overreaction? The case of pharmaceutical stock prices. Applied Economics. https://doi.org/10.1080/00036846.2011.562172
Source records
- hal · retrieved 2026-09-26T05:41:59.457Z